A mouse model of enterovirus d68 infection for assessment of the efficacy of inactivated vaccine

Viruses

Volumn 10, Issue 2, 2018, Pages

  Zhang, Chao ^a,b   Zhang, Xueyang ^b   Dai, Wenlong ^b   Liu, Qingwei ^b   Xiong, Pei ^b   Wang, Shuxia ^b   Geng, Lanlan ^a   Gong, Sitang ^a   Huang, Zhong ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Acute flaccid myelitis; Enterovirus D68; Inactivated vaccine; Mouse model; Neutralizing antibody

Indexed keywords

ENTEROVIRUS D68 VACCINE; INACTIVATED VACCINE; UNCLASSIFIED DRUG; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; DOSE RESPONSE; ELECTRON MICROSCOPY; ENTEROVIRUS D68; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LD50; MORTALITY RATE; MOUSE; MYOSITIS; NECROSIS; NONHUMAN; PASSIVE IMMUNIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; VIRULENCE; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; ENTEROVIRUS D; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MORTALITY; NEWBORN; PATHOLOGY; PHYSIOLOGY; SERODIAGNOSIS; TUMOR CELL LINE; VIRAL TROPISM; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENTEROVIRUS D, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; MICE; MICE, INBRED ICR; NEUTRALIZATION TESTS; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL TROPISM; VIRAL VACCINES;

EID: 85041416931     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v10020058     Document Type: Article

References (32)

1. Imamura, T.; Oshitani, H. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev. Med. Virol. 2015, 25, 102–114. [CrossRef] [PubMed]
2. Schieble, J.H.; Fox, V.L.; Lennette, E.H. A probable new human picornavirus associated with respiratory diseases. Am. J. Epidemiol. 1967, 85, 297–310. [CrossRef] [PubMed]
3. Tokarz, R.; Firth, C.; Madhi, S.A.; Howie, S.R.; Wu, W.; Sall, A.A.; Haq, S.; Briese, T.; Lipkin, W.I. Worldwide emergence of multiple clades of enterovirus 68. J. Gen. Virol. 2012, 93, 1952–1958. [CrossRef] [PubMed]
4. Holm-Hansen, C.C.; Midgley, S.E.; Fischer, T.K. Global emergence of enterovirus D68: A systematic review. Lancet Infect. Dis. 2016, 16, e64–e75. [CrossRef]
5. Xiang, Z.; Li, L.; Ren, L.; Guo, L.; Xie, Z.; Liu, C.; Li, T.; Luo, M.; Paranhos-Baccala, G.; Xu, W.; et al. Seroepidemiology of enterovirus D68 infection in China. Emerg. Microbes Infect. 2017, 6, e32. [CrossRef] [PubMed]
6. Messacar, K.; Robinson, C.C.; Pretty, K.; Yuan, J.; Dominguez, S.R. Surveillance for enterovirus D68 in Colorado children reveals continued circulation. J. Clin. Virol. 2017, 92, 39–41. [CrossRef] [PubMed]
7. Korematsu, S.; Nagashima, K.; Sato, Y.; Nagao, M.; Hasegawa, S.; Nakamura, H.; Sugiura, S.; Miura, K.; Okada, K.; Fujisawa, T. “Spike” in acute asthma exacerbations during enterovirus D68 epidemic in Japan: A nation-wide survey. Allergol. Int. 2018, 67, 55–60. [PubMed]
8. Dyrdak, R.; Grabbe, M.; Hammas, B.; Ekwall, J.; Hansson, K.E.; Luthander, J.; Naucler, P.; Reinius, H.; Rotzen-Ostlund, M.; Albert, J. Outbreak of enterovirus D68 of the new B3 lineage in Stockholm, Sweden, August to September 2016. Eurosurveillance 2016, 21, 30403. [CrossRef] [PubMed]
9. Knoester, M.; Scholvinck, E.H.; Poelman, R.; Smit, S.; Vermont, C.L.; Niesters, H.G.; van Leer-Buter, C.C. Upsurge of Enterovirus D68, The Netherlands, 2016. Emerg. Infect. Dis. 2017, 23, 140–143. [CrossRef] [PubMed]
10. Sejvar, J.J.; Lopez, A.S.; Cortese, M.M.; Leshem, E.; Pastula, D.M.; Miller, L.; Glaser, C.; Kambhampati, A.; Shioda, K.; Aliabadi, N.; et al. Acute Flaccid Myelitis in the United States, August–December 2014: Results of Nationwide Surveillance. Clin. Infect. Dis. 2016, 63, 737–745. [CrossRef] [PubMed]
11. Messacar, K.; Schreiner, T.L.; van Haren, K.; Yang, M.; Glaser, C.A.; Tyler, K.L.; Dominguez, S.R. Acute flaccid myelitis: A clinical review of US cases 2012–2015. Ann. Neurol. 2016, 80, 326–338. [CrossRef] [PubMed]
12. Perez, G.; Rosanova, M.T.; Freire, M.C.; Paz, M.I.; Ruvinsky, S.; Rugilo, C.; Ruggieri, V.; Cisterna, D.; Martiren, S.; Lema, C.; et al. Unusual increase of cases of myelitis in a pediatric hospital in Argentina. Archivos Argentinos de Pediatria 2017, 115, 364–369. [PubMed]
13. Chong, P.F.; Kira, R.; Mori, H.; Okumura, A.; Torisu, H.; Yasumoto, S.; Shimizu, H.; Fujimoto, T.; Hanaoka, N.; Kusunoki, S.; et al. Clinical Features of Acute Flaccid Myelitis Temporally Associated with an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August–December 2015. Clin. Infect. Dis. 2017. [CrossRef]
14. Ruggieri, V.; Paz, M.I.; Peretti, M.G.; Rugilo, C.; Bologna, R.; Freire, C.; Vergel, S.; Savransky, A. Enterovirus D68 infection in a cluster of children with acute flaccid myelitis, buenos aires, argentina, 2016. Eur. J. Paediatr. Neurol. 2017, 21, 884–890. [CrossRef] [PubMed]
15. Esposito, S.; Chidini, G.; Cinnante, C.; Napolitano, L.; Giannini, A.; Terranova, L.; Niesters, H.; Principi, N.; Calderini, E. Acute flaccid myelitis associated with enterovirus-D68 infection in an otherwise healthy child. Virol. J. 2017, 14, 4. [CrossRef] [PubMed]
16. Yoder, J.A.; Lloyd, M.; Zabrocki, L.; Auten, J. Pediatric acute flaccid paralysis: Enterovirus D68-Associated Anterior Myelitis. J. Emerg. Med. 2017, 53, e19–e23. [CrossRef] [PubMed]
17. Liu, Y.; Sheng, J.; Fokine, A.; Meng, G.; Shin, W.H.; Long, F.; Kuhn, R.J.; Kihara, D.; Rossmann, M.G. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 2015, 347, 71–74. [CrossRef] [PubMed]
18. Gong, Y.N.; Yang, S.L.; Shih, S.R.; Huang, Y.C.; Chang, P.Y.; Huang, C.G.; Kao, K.C.; Hu, H.C.; Liu, Y.C.; Tsao, K.C. Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis. Medicine 2016, 95, e4416. [CrossRef] [PubMed]
19. Zhang, Y.; Cao, J.; Zhang, S.; Lee, A.J.; Sun, G.; Larsen, C.N.; Zhao, H.; Gu, Z.; He, S.; Klem, E.B.; et al. Genetic changes found in a distinct clade of Enterovirus D68 associated with paralysis during the 2014 outbreak. Virus Evol. 2016, 2, vew015. [CrossRef] [PubMed]
20. Patel, M.C.; Wang, W.; Pletneva, L.M.; Rajagopala, S.V.; Tan, Y.; Hartert, T.V.; Boukhvalova, M.S.; Vogel, S.N.; Das, S.R.; Blanco, J.C. Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus). PLoS ONE 2016, 11, e0166336. [CrossRef] [PubMed]
21. Zheng, H.W.; Sun, M.; Guo, L.; Wang, J.J.; Song, J.; Li, J.Q.; Li, H.Z.; Ning, R.T.; Yang, Z.N.; Fan, H.T.; et al. Nasal Infection of Enterovirus D68 Leading to Lower Respiratory Tract Pathogenesis in Ferrets (Mustela putorius furo). Viruses 2017, 9, 104. [CrossRef] [PubMed]
22. Hixon, A.M.; Yu, G.; Leser, J.S.; Yagi, S.; Clarke, P.; Chiu, C.Y.; Tyler, K.L. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog. 2017, 13, e1006199. [CrossRef] [PubMed]
23. Ku, Z.; Shi, J.; Liu, Q.; Huang, Z. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. J. Virol. Methods 2012, 186, 193–197. [CrossRef] [PubMed]
24. Cai, Y.; Liu, Q.; Huang, X.; Li, D.; Ku, Z.; Zhang, Y.; Huang, Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 2013, 31, 2215–2221. [CrossRef] [PubMed]
25. Reed, L.J.; Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 1938, 27, 493–497. [CrossRef]
26. Zhang, C.; Zhang, X.; Zhang, W.; Dai, W.; Xie, J.; Ye, L.; Wang, H.; Chen, H.; Liu, Q.; Gong, S.; et al. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice. Emerg. Microbes Infect. 2018, 7, 3. [CrossRef] [PubMed]
27. Zhang, C.; Ku, Z.; Liu, Q.; Wang, X.; Chen, T.; Ye, X.; Li, D.; Jin, X.; Huang, Z. High-yield production of recombinant virus-like particles of enterovirus 71 in pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 2015, 33, 2335–2341. [CrossRef] [PubMed]
28. Ku, Z.; Ye, X.; Huang, X.; Cai, Y.; Liu, Q.; Li, Y.; Su, Z.; Huang, Z. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS ONE 2013, 8, e57601. [CrossRef] [PubMed]
29. Greninger, A.L.; Naccache, S.N.; Messacar, K.; Clayton, A.; Yu, G.; Somasekar, S.; Federman, S.; Stryke, D.; Anderson, C.; Yagi, S.; et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): A retrospective cohort study. Lancet Infect. Dis. 2015, 15, 671–682. [CrossRef]
30. Maloney, J.A.; Mirsky, D.M.; Messacar, K.; Dominguez, S.R.; Schreiner, T.; Stence, N.V. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. AJNR Am. J. Neuroradiol. 2015, 36, 245–250. [CrossRef] [PubMed]
31. Liu, C.C.; Guo, M.S.; Lin, F.H.; Hsiao, K.N.; Chang, K.H.; Chou, A.H.; Wang, Y.C.; Chen, Y.C.; Yang, C.S.; Chong, P.C. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS ONE 2011, 6, e20005. [CrossRef] [PubMed]
32. Chong, P.; Guo, M.S.; Lin, F.H.; Hsiao, K.N.; Weng, S.Y.; Chou, A.H.; Wang, J.R.; Hsieh, S.Y.; Su, I.J.; Liu, C.C. Immunological and biochemical characterization of coxsackie virus A16 viral particles. PLoS ONE 2012, 7, e49973. [CrossRef] [PubMed]